royalties

increase
Biotech

Royalty signs off $2B to bankroll Revolution's RAS cancer drug

Revolution secured the funding infusion from Royalty in return for a slice of the profits if Revolution's lead cancer drug makes it to market.
James Waldron Jun 24, 2025 9:00am
Gilead

Gilead pays J&J $320M to exit licensing deal for seladelpar

Aug 9, 2024 10:30am
cash runway cash airplane extend deal earnings

Ovid sells some royalty rights to Takeda-partnered seizure drug

Oct 18, 2023 8:00am
investment money shot vaccine pharma dollar

Blackstone, Sutro ink royalty pact worth up to $390M biobucks

Jun 26, 2023 1:47pm
crown jewels royalty

Arrowhead fills quiver with $250M Royalty deal

Nov 9, 2022 11:00am